Lunit Past Earnings Performance
Past criteria checks 0/6
Lunit has been growing earnings at an average annual rate of 5.9%, while the Healthcare Services industry saw earnings growing at 15.7% annually. Revenues have been growing at an average rate of 80.9% per year.
Key information
5.9%
Earnings growth rate
21.4%
EPS growth rate
Healthcare Services Industry Growth | 16.7% |
Revenue growth rate | 80.9% |
Return on equity | -15.7% |
Net Margin | -146.7% |
Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Revenue & Expenses BreakdownBeta
How Lunit makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Dec 23 | 25,080 | -36,798 | 46,526 | 16,639 |
30 Sep 23 | 23,626 | -39,226 | 42,968 | 15,163 |
30 Jun 23 | 24,805 | -44,762 | 41,820 | 15,275 |
31 Mar 23 | 21,861 | -19,443 | 42,327 | 15,617 |
31 Dec 22 | 13,866 | -39,118 | 42,792 | 18,364 |
30 Sep 22 | 14,017 | -42,801 | 41,620 | 20,592 |
30 Jun 22 | 10,715 | -52,413 | 38,900 | 20,868 |
Quality Earnings: A328130 is currently unprofitable.
Growing Profit Margin: A328130 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: Unable to establish if A328130's year-on-year earnings growth rate was positive over the past 5 years as it has been trading publicly for less than 3 years.
Accelerating Growth: Unable to compare A328130's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: A328130 is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (13.5%).
Return on Equity
High ROE: A328130 has a negative Return on Equity (-15.65%), as it is currently unprofitable.